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Cooperation between thymus-derived (T)  t and nonthymus-derived (B) cells occurs 
in primary and secondary humoral antibody responses of mice to heterologous erythro- 
cytes and serum proteins (1-3). Recent experiments have  demonstrated that T  as 
well as B cells can react to antigen specifically  and therefore  dictate the specificity  of 
the response (1, 4). Furthermore, the requirement for T  cells in antibody production 
appears to depend on the way in which antigen is presented rather than on the speci- 
ficity of the antigenic determinant concerned (5).  T  cells thus act as helper cells in 
facilitating the response of B cells to antigen. As recirculating small lymphocytes (6), 
T cells would be particularly well suited to the task of picking up antigen and concen- 
trating it in regions in lymphoid tissues where B cells reside.  Concentration may be 
an entirely passive process  in which antigen is focused  directly onto B cells, antigen 
bridges linking T  and B  cells  (7).  On the other  hand, antigen concentration may 
occur only after differentiation of  T  cells:  in other words,  these may first have to 
interact with some determinants on the antigen, differentiate, and divide to elaborate 
some factor that mediates the induction process.  This factor may be highly specific, 
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a  type of immunoglobulin molecule (IgX), serving to concentrate other determinants 
of the antigen onto B cells (8) ; or it may be a nonimmunoglobulin, nonantigen, specific 
factor carrying information in the form of the tertiary structure  of the antigenic de- 
terminant  and  capable  of  activating  B  cells  (9).  Alternatively,  the  factor  may  be 
nonspecific,  acting at short range to lower the threshold of stimulation of B  cells, a. 
type  of  pharmacological  mediator  analogous  to  those  produced  in  delayed  hyper-~ 
sensitivity reactions  (10). 
If T  cells act simply as passive carriers of antigen,  their function should be mim- 
icked by inert antigen-coated nonreactive cells, provided these are distributed in vivo 
in the same way as T  cells. The experiments reported here were designed to test this 
possibility. It will be shown that  triggering of either primed or unprimed B  cells, re- 
siding  in the spleen,  cannot be achieved by  delivering into  the spleen inert or non- 
reactive T  or B  cells artificially coated with the antigen in question, and that  differ- 
entiation of specific T  cells appears to be mandatory  in a  collaborative response. 
Materials and Methods 
Animals.taMale  and female mice of the highly inbred CBA and  C57BL strains  and  F1 
hybrids from crosses between these two strains were used. The pedigree and  maintenance of 
these mice have been given previously (11). White Leghorn fowls, 6 months old, were obtained 
from a commercial breeder and kept in suitable poultry cages. 
Cell Suspenslons.--Suspensions  of cells from thymus,  marrow,  spleen,  and  thoracic duct 
lymphocytes (TDL) were obtained as described before (11, 12). 
Antigens.--Fowl  immunoglobulin G  (F3'G), sheep erythrocytes (SRBC), and horse eryth- 
rocytes  (HRBC)  were  obtained  as  described  elsewhere  (11-13).  Human  gamma  globulin 
(HGG) was supplied from the Commonwealth Serum Laboratories, Melbourne, Australia, in 
10-ml vials containing 160 mg protein/ml. 4-hydroxy-3-iodo-5-nitrophenylacetic acid  (NIP) 
was prepared according to the method of Brownstone et ai.  (14). NIP azide was conjugated 
onto the proteins, F3'G or HGG, according to the technique given in Brownstone et al.  (14). 
The substitution ratio (groups  of hapten per mole of protein) was determined spectrophoto- 
metrically at 430 m/~ and the values for the extinction coefficient, k, was that given in Brown- 
stone et al.  (14). Conjugates with 10 hapten groups/molecule F3'G or HGG were generally 
used. 
Injections.--Cells  and antigens were injected intravenously or intraperitoneally as stated 
below. 
Operative Procedures.--The techniques of thymectomy (15) and of thoracic duct cannula- 
tion (11) have been given elsewhere. 
Irradiatibn.--Details  of the irradiation technique were given in the previous paper iv. this 
series  (3). When thymectomized mice were irradiated, they received within 1-3 hr an intra- 
venous injection of 5 X  106 syngeneic marrow cells. All irradiated mice were given polymyxin 
B  (100,000 IU/liter) and neomycin (10 mg/liter) in the drinking water. 
Immunization.--An intravenous injection of 4  X  10  s washed SRBC or HRBC was used to 
immuniz  e mice against  these heterologous erythrocytes.  Immunization  to protein antigens 
and to hapten-pl'otein conjugates was performed by giving 500/zg of alum-precipitated antigen 
and 2 X  109 killed pertussis organisms  2 intraperitoneally. The technique of alum precipitation 
was that of Proom (16). 100 #g of fluid protein antigen was given intraperitoneally as a booster 
in some experiments. 
2 Pertussis  vaccine (4)  10  l° killed organisms/ml),  Commonwealth Serum Laboratorie~ 
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Induction  of Tolerance to F'yG.--Adult mice were rendered tolerant to F3'G by the cyclo- 
phosphamide technique described in a previous paper in this series  (17). An intraperitoneal 
injection of 5 mg alum-precipltated FTG and 2  X  109 killed  pertussis organisms (F3'G AP) 
was followed the next day by a subcutaneous injection of cyclophosphamide  '~ using a dose of 
1 rag/10 g body weight. The mice were used 2 wk later. Assays for tolerance were performed 
in some mice after challenging with 500 #g of F3'G AP either by measuring the serum-binding 
capacity using radioiodinated F')'G (18) or by determining splenic anti-F3'G plaque-forming 
cells (PFC)  (13). 
Preparation of Antisera.--The following antisera were used: (a) mouse anti-H2 sera (CBA 
anti-C57BL and C57BL  anti-CBA) prepared as described before (11);  (b)  mouse anti-F3,G 
serum obtained by immunizing CBA mice with one intraperitoneal injection of 500 #g  of 
F'yG AP followed 6 wk later by one intraperitoneal injection of 100 #g of fluid F3'G, the mice 
being bled 7-10 days later; (c) anti-SRB  C immunoglobulin G (13) ; (d) fowl anti-mouse lympho- 
cyte serum (FALS) prepared by giving fowls two intravenous injections of 109 CBA or  (CBA 
X  C57BL)F1  thymus cells 3 wk apart followed 1 wk later by bleeding. The immunoglobulin 
G-containing fraction was separated from the serum by the technique described previously 
(13) and the fowl anti-mouse lymphocyte globulin (FALG) fraction titrated for its lympho- 
agglutinating activity and stored in small aliquots at --20°C; (e) rabbit anti-mouse lympho- 
cyte globulin (RALG) and normal rabbit globulin were prepared as described previously (19) ; 
(f) anti-0 C3H serum (20). 
Measurement of Antibody Acti~'ity.--The  anti-SRBC titer of the serum of mice immunized 
to SRBC was determined by hemagglutination assay (21). The titer of mouse anti-FTG serum 
was measured either by its hemagglutination activity against SRBC coated with FTG in the 
form of fowl anti-SRBC imrnunoglobulin G, as described elsewhere (13) or by microprecipita- 
tion assay with F3,G-125I, in a manner analogous to the previously described method of test- 
ing for anti-immunoglobulin sara (18). The antibody activity of the FALG and RALG prep- 
arations were titrated by the techniques of lymphocytotoxicity and lymphoagglutination (22). 
Detection of Antibody-Forming Cdls.--PFC in spleen cell suspensions were detected accord- 
ing to the method of Cunningham and Szenberg (23). The following target erythrocytes were 
used: (a) HRBC or SRBC to detect anti-HRBC and anti-SRBC PFC, respectively; (b) F3tG - 
coated SRBC to detect anti-F3~G PFC according to the technique of Miller and Warner (13) ; 
(c) NIP azide-coated SRBC according to the technique of Pasanen and M/ikel~  (24). Guinea 
pig serum served as a source of complement and a rabbit anti-mouse immunoglobulin serum 
diluted appropriately was added to detect indirect PFC as described elsewhere (25, 26). 
Preparation of Antigen-Coated Cdls.--Lymphoid cell suspensions  from the spleen or thoracic 
duct lymph were coated with antigen according to one of two methods.  (a)  FALG-coated 
cells were prepared as follows: 8  >(  107 TDL in 3.75 ml Eisen's balanced salt solution (27) 
was added 0.25  ml of FALG (4 mg IgG/ml) of known lymphoagglutinating titer. The sus- 
pension was incubated for 1 hr at 37°C and washed twice before injection, 2  )< 107 cells being 
given intravenously to each recipient. (b) A second method utilized the ability of B  cells to 
bind  antibody-antigen complexes (28).  Anti-F3'G-FTG.NIP-coated cells  were  obtained as 
follows: 5 X  107 spleen cells/ml were incubated for 30 rain at 37°C with 1  : 5 dilution of mouse 
anti-F3'G serum  (hemagglutinating titer 1:256).  The cells were then spun once, the super- 
natant removed, and the pellet resuspended (without washing) in Dulbecco's balanced salt 
solution (29) containing 100 #g F3'G.NIP/ml, 5  X  107 cells being suspended in 2 ml. After 
incubation for a further 30 rain at 37°C,  the cells were washed twice and 2  )<  107 iujected 
intravenously into each recipient. 
Radioisotopes.~lCr as Na2CrO4 in isotonic saline and lzsI were obtained from the Radio- 
chemical Centre, AmershanL Buckinghamshire, England. FALG was trace labeled with l~I 
Cyclophosphamide (endoxan, asta), Charles McDonald, Caringbah, Australia. MILLER  ET AL.  1269 
by the method of Byrt and Ada (30), using a low substitution rate (1 iodine atom/molecule) 
so as not to interfere with antibody activity, 
Labeling Cells Radioactively and Tracing Their Distribution.--In  some experiments, TDL 
were labeled with 51Cr and their localization in the liver and spleen, 4  hr after intravenous 
injection into mice, was determined according to the technique described  by Martin  (31). 
In other experiments, TDL were incubated in vitro with trace labeled FALG-125I (1 #g FALG/ 
107 cells) for 1 hr at 37°C.  Excess radioactivity was removed by centrifugation through fetal 
calf serum  4 gradients. Approximately 4  X  107 FALG-125I-coated TDL were injected intra- 
venously into mice as described below. Radioautographs of spleen sections and TDL smears 
were prepared, at appropriate times, the slides being dipped in Eastman Kodak NTB-2 emul- 
sion, developed, and stained. 
Antimetabolite Treatment o/Lympho6ytes.--5  X  107  TDL/ml  Dulbecco's  solution were 
incubated in vitro at 37°C for ~  hr with 25 #g mitomycin C~/ml, and then washed twice. The 
viability of the mitomycin-treated TDL was 98% as determined by the trypan blue exclusion 
technique (32). 
Statistical Analysis.--Caiculations  of the geometric means, upper and lower limits of the 
SE and P  values according to the nonparametric rank test, were performed using an IBM 
7044 computer. In comparison of the means of any two groups of observations, a significance 
level of 0.05 was chosen. 
EXPERIMENTAL  PROCEDURE 
The aim of these experiments was to study the response of thymus-deprived mice 
given lymphoeytes which lacked specific  T  cells  capable of reacting with a particular 
antigen but which could be artificially  coated with that antigen. One further require- 
ment was that the cells  should home to the spleen after  injection.  In one set of experi- 
ments TDL  from mice rendered specifically  tolerant to F'yG were incubated with 
FALG  which coated the cells  because of its antibody activity.  FALG  was found not 
to be immunosuppressive  in mice and had neither cytotoxic nor opsonizing  effects. 
The FALG-coated  cells  migrated as normal lymphocytes after intravenous  injection 
into mice. A  second set of experiments utilized  the recent finding that B  cells  can be 
coated with antibody-antigen  complexes (28).  Spleen from thymectomized, irradiated, 
and marrow protected  (TxBM)  mice served as a source of B  cells  which were incu- 
bated with anti-F'yG-F'yG.NIP  and injected together with NIP-sensitive  cells  into 
irradiated mice. The capacity of the TxBM  mice in the first  set of experiments and 
of the irradiated  mice in the second set to  produce an antibody response to the antigen 
in question was then tested with or without added T  cells. 
RESULTS 
Effect of Incubating Mouse TDL with FALG.--The lymphoagglutinating and 
lymphocytotoxic titers of two batches of FALG against mouse TDL are shown 
in Table I. Even normal F~G had some agglutinating activity. This was in- 
creased markedly by immunizing fowls with mouse thymus lymphocytes. The 
FALG preparations were not cytotoxic  for mouse TDL in the presence of guinea 
pig complement. This was expected since avian immunoglobulins do not bind 
mammalian complement (33). 
4 Fetal calf serum was obtained from Commonwealth Serum Laboratories. 
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Distribution  of  FALG-Coated  TDL.--The  localization  of  FALG-incubated 
51Cr-labeled  TDL  was  studied  after  intravenous  injection  into  normal  mice. 
Radioactivity was determined in the liver and  spleen  4 hr after injection.  No 
significant "opsonization" of mouse TDL resulted from incubation with FALG 
(Table II). By contrast, a high proportion of TDL were opsonized by the refer- 
ence RALG preparation, as had been found in previous work (22, 31). 
TABLE I 
Effects  of FALG on Mouse TDL In Vitro 
Preparation  Lymphoagglutinating titer  Lymphocytotoxic index* 
Dulbecco's medium  0  0 
F'yG  1:16  0 
FALG1  1:128  0 
FAL  C,2  1: 64  0 
* Trypan blue exclusion technique  (32). 
TABLE II 
Diversion  of Mouse  TDL from  Spleen  to Liver 
after Incubation  with Various  Antisera 
TDL diverted to liver 
Serum used  (in excess of normal 
percentage)*. 
% 
NFS§  1.40 
FALSx  1.39 
FALS~  1.41 
F3,G  1.09 
FALGI  1.07 
FALG2  0.99 
RALG  79.00 
* For calculations see reference 31. 
:~ Average of eight test  mice used 
serum. 
§ NFS, normal fowl serum. 
for each 
Radioautographs of smears of TDL incubated with FALG-nSI were prepared. 
More than 95 %  of these cells  showed binding of the radioiodinated  material. 
4 X  107-labeled TDL were injected intravenously either into intact mice, which 
were killed 4, 12, and 24 hr later to provide spleen sections, or into mice in which 
a  thoracic duct fistula  had been  established.  Among the TDL emerging from 
these mice in the  ensuing  12-36  hr,  no cell carrying labeled  material  was de- 
tected. Examination of the spleen sections revealed that even as early as 4 hr 
after injection, only the occasional cell still  carried the FALG, the majority of 
the label being scattered throughout the white pulp. MILLER  ET  AL. 
TABLE  III 
Serum Anti-F~/G Antibody in (CBA  X  C57BL)F1 Mice Given F'yG AP and 
Cyclophosphamide 2 Wk before 
1271 
Group*  Pretreatment  Antigen challenge 
2 wk later 
Reciprocal serum 
antibody titers 15 
days postchallenge 
50% precip-  Hemag- 
itatlon of  glutinm 
Fq~G-125I  titer 
by serum  (SRBC) 
Day 1: saline  500#g F'yG AP and  120  128 
Day 2: saline  4  X  108 SRBC  160  256 
160  512 
240  256 
Day 1: saline  500 #g F'yG AP and  160  256 
Day 2: cyclophosphamide  4  X  l0  s SRBC  240  64 
240  512 
320  1024 
Day 1 : 5 mg F3'G AP  500 #g F3'G AP and  < 1  64 
Day 2: cyclophosphamide  4  X  108 SRBC  < 1  256 
<1  256 
<1  512 
* Four mice per group. 
TABLE  IV 
Anti-F'yG PFC Response in Spleens of Nontolerant or F'yG-Tolerant (CBA  X  C57BL)F1 Mice 
or TxBM CBA Mice 
Group 
1 
2 
3 
4 
Pretreatment of mice 
Day 1: saline 
Day 2: saline 
Day I: saline 
Day  2:  cyclophos- 
phamide 
Day 1  : 5 mg F'yG AP 
Day 2: cyclo. 
TxBM 
No, of 
Antigen  mice in 
challenge  group* 
500 #g F'yG AP 
2 wk later 
500/~g F3'G AP 
2 wk later 
500 #g F'yG AP 
2 wk later 
500 #g F3'G AP 
2 wk postirradi- 
ation 
Anti-F'yG PFC per spleen 
19S PFC:~ (4-5 days)  7S PFC~ (6-7 days) 
12 
12 
12 
16 
20,530 (23,240-18,140)§ 
16,850 (17,960-15,800)  1 
70  (180-30)  J 
510  (700-370) 
58,010 (76,400-44,050) 
33,060  (40,080-27,260)] 
5  (17-2)  Il] 
2 (4-1) 
* Half the mice were killed at 4-5 days to determine I9S PFC, the other half at 6-7 days to assay 7S PFC, 
$19S PFC, direct plaque-forming  cells; 7S PFC, indirect or developed plaque-forming  cells. 
§ Geometric means, upper and lower limits of sE. 
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Induction of Tolerance to F'yG in Adult Mice.--The cyclophosphamide method 
was highly successful in inducing specific immunological tolerance to FTG in 
mice as indicated by the low serum antibody titers and splenic anti-F3,G PFC 
(Tables III and IV). The state of unresponsiveness was specific since the mice 
could respond normally to SRBC  (Table III). The peak 19S and 7S anti-F3,G 
PFC response in F~G-tolerant mice was of the same order of magnitude as that 
occurring after challenging  (TxBM)  mice with F3'G AP  (Table IV). The low 
response of these thynlectomized animals is in accordance with previous studies 
indicating  thymus-dependency of  the  humoral  antibody respons  e  of mice to 
FTG (13). 
TABLE  V 
Serum Anti-F'yG Antibody in TxBM CBA Mice Receiving TDL from Nontolerant 
or FTG-Tolerant (C57BL X CBA)F1  Mice 
None 
TDL given 
X  10  7 cells from 
F3'G-tolerant mice 
X  10  7 cells from 
cyclophosphamide- 
pretreated mice 
Antigen challenge in vivo 
500 #g F3'G AP 
and 4 X 10  s SRBC 
500/zg F3tG AP 
and 4 X 108 SRBC 
500 #g F'yG AP 
and 4 X 108 SRBC 
Anti-FTG antibody (%FTG-nsI 
bound/10 D1 antiserum) 
15 days 
12.1  (7)* 
2.6  (11) 
11.5  (12) 
22 days 
2.8  (6) 
0.5  (11) 
50.4  (10~ 
42 days 
26.0  (3) 
2.2  (6) 
61.8  (5) 
Range of peak 
reciprocal anti- 
SRBC hemag- 
glutlnin titer 
(15 or 22 days) 
<2-4  (7) 
32-1024  (11) 
32-1024  (12) 
* No. of mice is shown in parentheses. 
Adoptive  Transfer of Antibody Response  to  F3,G.--Since  TxBM  CBA  mice 
failed to respond to FTG, they were used  as recipients  of (CBA  X  C57BL)F1 
TDL to study the capacity of normal and tolerant TDL populations to transfer 
adoptive primary antibody responses to F3'G. When 500  #g of FTG AP  was 
given i, vivo to TxBM mice, only recipients of nontolerant TDL coul  d respond 
to FyG (Table V). TxBM mice receiving TDL from F-yG-tolerant donors had 
very  little  detect~ble  serum  antibody  to  FTG,  although  they  could  now 
produce antibody to SRBC. When instead of giving F~,G in vivo, the TDL were 
incubated in vitro with FALG, washed, and injected intravenously into TxBM 
mice, again only recipients of nontolerant TDL responded to FTG whereas mice 
given FTG-tolerant TDL failed to do so, although a good response to SRBC was 
obtained (Table VI). It is clear from these results that FALG is not immuno- 
suppressive in mice and that FALG-coated TDL can adoptively transfer anti- 
body  responsiveness  to  F3,G  provided  they  are  obtained  from nontolerant 
donors. MILLER  ET  AL.  1273 
Similar results were obtained in separate experiments when the response was 
measured  in terms  of PFC per spleen.  Here the control antigen  could not be 
SRBC  (since F-rG-sensitized  SRBC  were  the  target  erythrocytes used  in the 
TABLE VI 
Serum Anti-F~G Antibody in TxBM CBA Mice Receiving FALG Incubated TDL 
from Nontolerant or F-rG-Tolerant (C57BL X  CBA)Ft Mice 
TDL given 
None 
2 )< 10  7 cells from F'yG-tolerant 
mice 
2 X 10  7 cells from cyclophos- 
phamide-pretreated  mice 
Antigen 
challenge 
in vivo 
4  X  10  s 
SRBC 
4  X  10  s 
SRBC 
4  X  10  s 
SRBC 
Anti-F'yG antibody (% F'yG-l~sI 
bound/10/zl antiserum) 
15 days 
0.5  (8)* 
1.2  (19) 
22.6  (11) 
22 days 
0.2  (8) 
1.4  (18) 
17.1  (11) 
42 days 
1.o  (6) 
12.1  (10 
42.0  (8) 
Range of 
peak reciprocal 
anti-SRBChe- 
magglutinin titer 
(15 or 22 days) 
<2-16  (8) 
32-128  (13) 
32-512  (8) 
* No. of mice is shown in parentheses. 
TABLE VII 
Anti-FTG PFC Response in Spleens of TxBM CBA Mice Receiving TDL from Nontolerant 
or F-rG-tolerant (CBA  X  C57BL) Fi Mice 
TDL given 
Antigen  No. of 
challenge  mice in 
in vivo  group* 
Peak anti-F'yG PFC per spleen 
19S PFC  7S PFC 
Per cent reduction of 
PFC with 
CBA anti-  C57BL  anti- 
C57BL  CBA 
serum  serum 
None  500/zg 
FTG AP 
2 wk post- 
irradi- 
ation 
2 X  l0  T ceils  500/~g 
from F*rG-tole-  FTG AP 
rant mice 
2  X  107  ceils  500/.tg 
from  cyclo-  F'gG AP 
phosphamide- 
pretreated 
mice 
16  510  (7000370)~, §  2  (4-1)§ 
12  230  (760°70)  ~  210  (300-140)  ~  --  -- 
II  1  II 
12  2620 (3270-2090)J  16,600  (20,350013,530)J  25% (19S)  83%  (19S) 
10% (7S)  90%  (TS) 
* Half the mice were killed at 5--6 days to determine 19S PFC, the other half at 7 days to assay 7S PFC. 
Geometric means, upper and lower limits of sE. 
§ Data from Table IV, group 4. 
II P  Values  <  0.005. 
anti-F'rG PFC assay). HRBC were used instead. When FTG was given in vivo, 
only TxBM  recipients  of  nontolerant  TDL  could  produce  a  good anti-F3,G 
PFC response. Treatment of these PFC with anti-H2 serum identified them as 
derived from the cells of the TxBM hosts and not from the TDL (Table VII). 1274  CELL-TO-CELL  INTERACTION  IN  THE  IMMUNE  RESPONSE.  VII 
When the TDL were incubated in vitro with  FALG, only nontolerant TDL 
enabled their hosts  to respond by producing anti-FvG PFC  and  these were 
derived, not from the TDL, but from the hosts. The responsiveness to HRBC in 
TxBM recipients of both  nontolerant  and  F~,G-tolerant TDL,  incubated  in 
vitro with FALG, established the specificity of tolerance in the TDL population 
and the failure of FALG to act as an immunosuppressant in mice (Table VIII). 
The inability of tolerant TDL,  artificially coated with  F~,G  (in  the form of 
FALG), to induce a  response in TxBM hosts, which do not lack B  cells,  sug- 
gested  that  normal T  cells  with  receptors specific for F~,G  were required  to 
facilitate antibody formation. Whether differentiation of specific T  cells was 
essential was examined with the aid of antimetabolites. 
Effect of Mitomycin C on the Ability of TDL to Transfer Antibody Responsive- 
ness.--The ability of normal TDL to transfer anti-F~,G activity to TxBM mice 
is evident from the above results. This occurred both when the recipients were 
challenged in vivo with F~,G or when they were not challenged but received, 
instead, FALG-coated cells.  By contrast, TDL from FTG-tolerant mice failed 
to transfer responsiveness to FTG under identical experimental situations.  As 
shown in Table IX, this failure (group 1) could readily be reversed by supple- 
menting with normal TDL (group 2). If, however, the normal TDL had previ- 
ously been incubated in vitro with mitomycin C and then washed,  they were 
unable either to transfer, on their own, a primary adoptive response to F~,G or 
HRBC (group 4), or to reverse the failure of tolerant TDL to allow TxBM hosts 
to respond to F~,G (group 5). The fact that a response to HRBC was obtained 
in TxBM recipients of a mixed population of F-yG-tolerant TDL and mitomy- 
cin-treated normal TDL excluded the possibility of carry over of antimetabolite 
from one population to the other. As seen in Table X, the ability of mitomycin- 
treated TDL from F~,G-primed mice to interact with the B  cells (obtained by 
anti-0 treatment of FvG-primed spleen cells) was likewise impaired. The degree 
of impairment (10-100-fold) was measured by comparing the collaborative re- 
sponse of 107 mitomycin-treated primed TDL (group 7)  with  that  of graded 
numbers of untreated primed TDL (groups 4 and 6). Reversal of mitomycin- 
induced suppression with normal TDL (group 9) established that carry over to 
B cells did not occur. The viability of TDL exposed to the antimetabolite was 
determined by using the dye exclusion technique: over 98 % of cells were viable 
according to this parameter. The localization of ~lCr-labeled  mitomycin-treated 
TDL after injection into mice was found to be normal (Table XI). It would 
seem, therefore, that mitomycin impaired the ability of specific T cells to collab- 
orate with B  cells in both primary and secondary responses. Presumably this 
occurred as a result of interference with differentiation and/or division. 
Adoptive  Transfer of Antibody Response to NIP.--In  the above experiments, 
a  tolerant TDL population  (composed mostly of T  cells  [6]) was  artificially 
coated with the antigen and used essentially as antigen-coated "particles" able MILLER  ET  AL.  1275 
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to deliver the antigen into the spleen where B  cells capable of producing anti- 
body reside. No response was obtained in the absence of specific T  cells which 
could differentiate and/or divide. In the following experiments, B  cells, not T 
cells,  were used as antigen-bearing particles. The technique utilized the ability 
of B  cells to bind antibody-antigen  complexes (28).  Cells  from the  spleen  of 
TxBM mice (which contain B cells relatively uncontaminated by T  cells)  were 
TABLE IX 
Anti-F'yG PFC Response  in  Spleens  of TxBM CBA  Mice Receiving  FALG-Incubated  TDL 
from Nontolerant  or F'yG-tolerant CBA Mice: Effect of Mitomycin Treatment  of 
Normal TDL as a Source of Unprimed T  Cells 
GrOup  TDL given 
Antigen  No. of 
chal-  mice 
.lenge  in 
In VlVO  group 
7S PFC per spleen at 7 days 
Anti-F3'G*  Anti-HRBC~ 
l  2X 107 FALG-incubated cells  4  X  108  6  4  (8-2)§  33,480  (36,001~31,150) 
from  Fq'G-tolerant  CBA  HRBC 
mice 
2  2  X  107  FALG-incubated  4  X  108  6  7100  (7790-6470)  43,980  (58,920-32,830) 
cells  from  F'yG-tolerant  HRBC 
CBA mice +  2  X  107 cells 
from normal CBA mlce 
3  2  X  107  FALG-incubated  4  X  l0 s  4  8380  (11,330-6200)  25,640  (28,180-23,320) 
cells  from  normal  CBA  HRBC 
mice 
4  2  X  107  mitomycin-treated  4  X  108  4  l0  (5-2)  250  (1630-40) 
and  FALG-incubated  cells  HRBC 
from normal CBA mice 
5  2  X  107  FALG-incubated  4  X  108  6  400  (590-270)  58,350  (73,280-46,470) 
cells  from  F3'G-tolerant  HRBC 
CBA mice +  2 X  107 mito- 
mycin-treated  cells  from 
normal  CBA mice 
* The differences between anti-FyG PFC in groups 1 and 2, 3 and 4, and 3 and 5 were  significant  (P  <  0.01) 
Anti-F3,G PFC in groups 2 and 3 did not differ significantly. 
:~ The differences between anti-HRBC PFC in groups 3 and 4 were significant (P <  0.0t). 
§ Geometric means, upper and lower limits of sE. 
preincubated in vitro with  anti-F3,G-F3,G-NIP and injected with or without 
nornaal TDL (a source of T  cells)  into hosts that had received 800 R  total body 
irradiation. Only mice given both cell types could produce an anti-NIP antibody 
response (Table XII). Thus, when B cells were used as antigen-bearing particles 
a primary response did not take place, unless T  cells were present. Radioauto- 
graphic observations, to be given in detail elsewher@ have shown  that B  cells 
6 A. Basten, J. F. A. P. Miller, J. Sprent, and J. Pye. Receptors for antibody-antigen com- 
plexes on B lymphocytes. Manuscript in preparation. MILLER  ET  AL.  1277 
TABLE X 
Anti-F~/G  PFC Response  in Spleens  of Irradiated  Mice Receiving  T  and  B  Cells: Effect  of 
Mitomycin C Treatment  of Primed TDL as a Source of Primal T  Cells 
Group 
10 
11 
Cells given 
5  X  106  NMS-treated§  spleen  cells from 
F~,G-primed mice 
5  X  10  6 anti-0-treated  spleen cells[] from 
F'yG-primed mice (primed B cells) 
10  5 TDL from F'yG-primed mice +  primed 
B cells 
10  5 TDL from F~'G-primed mice 
106 TDL from F'yG-primed mice ~  primed 
B cells 
106 TDL from F~'G-primed mice 
107 TDL from F'yG-primed mice¶ 
107 mitomycin-treated TDL** from F~'G- 
primed mice ~  primed B cells 
107 mitomycin-treated TDL** from F'yG- 
primed mice 
107 mitomycin-treated TDL** from F'yG- 
primed mice -t- primed B cells and 5 X 106 
normal TDL 
10  7 normal TDL 
No. of 
irradiated 
recip- 
ients* 
7S anti-F~GPFC per 
spleen at 7 days$ 
38,170  (47,860-30,020) 
130  (180-90) 
5600  (8730-3620) 
150  (410-50) 
46,370  (69,000-31,170) 
5710  (8520-3820) 
224,000  (400,000-145,000) 
9320  (13,400-6480) 
290  (1270-70) 
60,440  (81,060-45,000) 
1460  (1830-1170) 
* 100 #g fluid F'yG/recipient. 
The differences in PFC responses between groups  1 and  2, 2  and  3, 2 and 5, 5 and' 8, 8 
and 10 were significant (P values <0.05). 
§ NMS, normal mouse serum. 
[I Cells incubated with anti-0 serum (1:4) at concentration  15 X  107 cells/ml plus guinea 
pig complement (1:6)  at concentration of 5  X  107 cells/ml. 
¶ The addition of primed B  cells did not significantly enhance the PFC response in this 
instance and the data have therefore been excluded. 
** TDL incubated with 25 ~g/ml mitomycin C at a concentration of 5 X  107 cells/ml. 1278  CELL-TO-CELL  INTERACTION  IN  THE  IMMUNE  RESPONSE.  VII 
coated in this way homed to the spleen with labeled antigen which eluted during 
the next 24 hr. 
The B  cells in the above experiment were derived from nonprimed mice. It 
remained possible that primed B cells could be induced to respond in the absence 
TABLE  XI 
Effect of Mitomycin  on Localization of Mouse 
TDL in Spleen and Liver 
Medium used to  Spleen  radioactivity: 
incubate TDL*  liver radioactivity 
Dulbecco's solution  1.63 
Dulbecco's solution con-  1.38 
taining  25#g mitomy- 
cin/ml 
* 51Cr-labeled TDL incubated for 30 min at 
37°C; 5 X  10  ~ TDL injected into each of four 
recipients;  livers  and  spleens removed  4  hr 
later. 
TABLE XlI 
Adoptive Transfer of Primary Anti-NIP PFC Response by Antigen-Coated B Cells 
No. of 
No. and  irradiated  19S anti-NIP PFC  No. and source of B  cells  source of  recip-  per spleen at 7 days 
T  cells  ients 
2  X  107 spleen cells from TxBM mice prein-  --  10  40  (60-20)*, :~ 
cubated with anti-F~/G antibody and FTG. 
NIP 
2  X  107 spleen cells from TxBM  mice prein-  5 X 106 
cubated with anti-F'~G antibody and F3'G.  normal 
NIP  TDL 
5  X 106 
normal 
TDL 
lo  710  (800-640)~ 
10§  70  (80-65) 
* Geometric means, upper and lower limits of sE. 
:~ Addition of spleen cells from TxBM mice, not incubated  with antibody and antigen, 
made no difference to these results. 
§ These 10 mice received 500 #g of F'yG AP in vivo. 
of T  cells. Since TxBM mice could not be primed to NIP by immunizing with 
F~,G.NIP, the following two experiments were performed. Mice were immu- 
nized with HGG. NIP and used 1-2 months later as donors of spleen cells con- 
taining B  cells primed to NIP. These cells were injected into irradiated mice MILLER  ET  AL.  1279 
which were challenged with either HGG.NIP or FTG'NIP. The former pro- 
duced a good response, the latter, a poor one (Table XIII). The response of mice 
challenged with F'rG. NIP was considerably enhanced by adding spleen cells 
from other mice primed only to the heterologous carrier protein, F3,G. These 
results  essentially confirm previous work with  hapten-protein  conjugates,  in 
which the necessity for carrier-primed T  cells was established (7). In a second 
experiment, irradiated mice received a mixed population of two types of spleen 
cells: one was obtained from TxBM mice and incubated in vitro with anti-F~,G- 
F~G.NIP; the other from HGG.NIP-primed mice. The irradiated mice were 
not challenged with antigen other than that carried by the cells from TxBM 
mice. As shown in Table XIV,  a  good anti-NIP PFC response was obtained. 
This might at first sight imply that antigen-coated B cells could substitute for 
carrier-primed T cells. If, however, the spleen cells from HGG. NIP-primed mice 
TABLE  XIII 
Adoptive Transfer of Anti-NIP PFC Response in CBA Mice 
Donor of spleen  cells*  Anti[[en challenge  No. of  in vivo$  irradiated  7S anti-NIP PFC per spleen  at 7 days 
recipients 
HGG.NIP-primed mice 
HGG. NIP-primed mice 
HGG. NIP-primed mice 
and  F3"G-primed  mice 
HGG'NIP  6  452,000  (598,180-341,490)§ 
F3tG" NIP  8  4210  (8740-2020) 
F3'G" NIP  5  118,170  (126,900-110,050) 
* 2 )<  107 spleen cells from each donor given to each recipient. 
:~ 100/zg of fluid antigen given intraperitoneally. 
§ Geometric means, upper and lower limits of SE. 
were pretreated in vitro with anti-8 serum and complement, to eliminate the 
majority  of T  cells from  this  population,  the  NIP  response  was  abolished 
(Table XIV). It was restored by supplementing with normal spleen cells (which 
contain T  cells). The results therefore indicate that antigen-coated B cells can- 
not substitute for T  cells even when primed B cells are present. T cells are thus 
required for both normal and primed B cells to respond to the antigen. 
DISCUSSION 
Two points clearly emerge from the experiments described. First, T  cells are 
specifically involved in inducing unprimed or primed B  cells to produce anti- 
body. Second, T  cells must,  themselves, react with the antigen and undergo 
differentiation before they can influence B cells. 
The requirement for T cells was examined by attempting to induce a response 
in unprimed or primed B  cells to antigens carried on the surface of cells which 
were essentially inert or nonreactive. Antigen-coated cells were prepared in two 
different ways. In the first, TDL from F'rG-tolerant mice were incubated in 1280  CELL-TO-CELL  INTERACTION  IN  THE  IMMUNE  RESPONSE.  VII 
vitro with FALG (which was shown not to be immunosuppressive in mice) to 
provide a source of F-yG-coated cells. These had normal migratory characteris- 
tics and therefore homed to the spleen in the same way as uncoated TDL. On 
injection into thymectomized irradiated mice, a response to HRBC but not to 
F~,G was obtained even though the hosts were shown to contain B cells capable 
of responding to F'~G (Table VIII). The second method of coating cells with 
antigen was based on the fact that B cells possess a receptor for antibody-anti- 
gen complexes (28).  Cells  from the spleens of TxBM mice were incubated in 
TABLE XIV 
Adoptive Transfer of Secondary Anti-NIP PFC Response by Antigen-Coated 
B Cells and NIP-Primed Cells 
Group  Source of B  cells*  Source of NIP-primed  Supple-  No. of  7S anti-NIP PFC per  cells*  mentary  irradiated 
cells  recipients  spleen at 7 days:~ 
l  Spleen  cells  from  TxBM  Spleen  cells  from  HGG.  --  10  18,495  (20,545-16,645)§ 
mice  preincubated  with  NIP-primed mice prein- 
anti-F'yG  antibody  and  cubated with NMS 
F'yG.NIP 
2  Spleen  cells  from  TxBM  Spleen  cells  from  HGG.  --  9  70  (170-25) 
mice  preincubated  with  NIP-primed  mice prein- 
anti-FyG  antibody  and  cubated with anti-0][  se- 
F3,G.NIP  rum 
3  Spleen  cells  from  TxBM  Spleen  cells  from  HGG.  5 X  105  4  80  (360-20) 
mice  preincubated  with  NIP-primed  mice prein-  normal 
anti-FTG  antibody  and  cubated with anti-0[[  se-  spleen 
F3,G.NIP  rum  cells 
4  Spleen  cells  from  TxBM  Spleen  cells  from  HGG.  107  nor-  4  2640  (3340-2000) 
mice  preincubated  with  NIP-primed mice preln-  real 
anti-F'yG  antibody  and  cubated  with  anti-011  spleen 
F3'G. NIP  serum  cells 
5  Spleen  cells  from  normal  Spleen  cells  from  HGG.  --  6  15  (40-5) 
mice  preincubated  with  NIP-primed  mice prein- 
NMS and F'yG.NIP  cubated with NMS 
* Number of cells was 2 X  107/recipient. 
:~ The differences in PFC responses between groups I  and 2, 4 and 2, 4 and 3 were significant (P  <  0.002,  P  <  0.01 
P  <  0.05). 
§ Geometric means, upper and lower limits of s~. 
[1 Treatment with antl-0  serum as in Table X. 
vitro with anti-FTG-F-yG-NIP, washed, and injected into irradiated mice. A 
19S anti-NIP antibody response was obtained, but only if normal T  ceils, in the 
form of TDL, were also given (Table XII). A 7S anti-NIP antibody response 
occurred in irradiated mice given both NIP-coated B cells, prepared as above, 
and NIP-primed cells obtained from the spleens  of HGG.NIP-primed mice 
(Table XIV). This response was, however, abolished by eliminating the T  cells 
present in the spleens of the primed mice by treatment with anti-0 serum and 
complement  (Table  XIV).  Some  reconstitution  of  the  NIP  response  was 
achieved by supplementing with normal spleen cells. T  cells must thus be spe- 
cifically involved in inducing unprimed or primed B cells to produce antibody. MILLER ET  AL.  1281 
The antigen-coated nonreactive T  or B cells evidently acted as a means of con- 
centrating antigen into the spleen where it eluted and presumably was made 
available to specific T  cells. Only then could collaboration take place. 
The ability of irradiated recipients of spleen cells from HGG.NIP-primed 
mice and of F~G.NIP-coated B  cells  to produce a  substantial  anti-NIP  re- 
sponse (Table XIV) provides another example of overriding of the carrier effect 
(34). In the present model, overriding occurred only in the presence of T  cells 
since  anti-0  serum  treatment  of  spleen  cells  from  HGG.NIP-primed  mice 
abrogated the response. The data are therefore consistent with the previous ob- 
servation that, for an adoptive memory response, T  cells are essential but need 
not be derived from mice primed to the antigen in question: in other words, 
normal T cells can substitute for specifically primed T  cells (3). 
Treatment of TDL (a source of T cells) from both unprimed and primed mice 
with mitomycin C impaired their ability to collaborate with B cells (Tables IX 
and X). In contrast, Katz et al. found little impairment in function of carrier 
specific cells (known to be T  cells [35, 36]) after irradiation in vitro (37). The 
effectiveness of mitomycin C in abrogating T cell function may therefore depend 
not so much on its antimitotic activity as on its capacity to interfere with cell 
differentiation at the dose level used (38). The failure of mitomycin  7 as well as 
irradiation (39) to prevent collaboration of activated thymus cells (which have 
already undergone some degree of differentiation) with B  cells in vitro is con- 
sistent with this interpretation. Taken together these findings suggest that the 
helper function of T  cells may be dependent on  cell  differentiation,  not  on 
cell division. Thus before collaboration can occur, T  cells need to be activated 
by antigen to differentiate to produce some factor essential  for triggering B 
cells.  As mentioned in  the  introduction,  this  factor may be specific or non- 
specific with respect to the antigenic determinants concerned. 
SUMMARY 
Experiments were designed to test the possibility that thymus-derived (T) 
cells cooperate with nonthymus derived (B) cells in antibody responses by acting 
as passive carriers of antigen. Thoracic duct lymphocytes (TDL) from fowl ~G- 
tolerant mice were incubated in vitro with fowl anti-mouse lymphocyte globulin 
(FALG), which was shown not to be immunosuppressive in mice. On transfer 
into adult thymectomized, irradiated, and marrow protected (TxBM) hosts to- 
gether with a control antigen, horse RBC, a response to horse RBC  but not to 
fowl -yG was obtained. By contrast, TxBM recipients of nontolerant, FALG- 
coated TDL responded to both antigens and the antibody-forming cells were 
shown to be derived from the host, not from the injected TDL. These findings 
suggested that, under the conditions of the experiment, triggering of unprimed 
7 Feldmann, M., and A. Basten. Unpublished data. 1282  CELL-TO-CELL  INTERACTION  IN  THE  IMMUNE  RESPONSE.  VII 
B  cells  in  the  spleens  of TxBM  hosts was not  achieved with  antigen-coated 
tolerant lymphocytes. 
Another model utilized the ability of B  cells to bind antibody-antigen com- 
plexes. Spleen cells from TxBM mice, incubated  in vitro with anti-fowl 3'G- 
fowl "rG.NIP, were injected with or without normal TDL (a source of T  cells) 
into irradiated hosts. Only mice given both cell types could produce an anti-NIP 
antibody response. In a further experiment, spleen cells from HGG. NIP-primed 
mice were injected together with NIP-coated B  cells (prepared as above) into 
irradiated  hosts. A substantial  anti-NIP antibody response occurred. If, how- 
ever, the T  cells in the spleens of HGG.NIP-primed mice were eliminated by 
treatment with anti-0 serum and conlplement, the NIP response was abolished. 
It was concluded  that antigen-coated B  cells could not substitute  for T  cells 
either in the primary or secondary response. 
Treatment of T  cells from unprimed or primed mice with mitomycin C im- 
paired their capacity to collaborate with B cells on transfer into irradiated hosts. 
Taken together these findings suggest that before collaboration can take place T 
cells must be activated by antigen to differentiate and in so doing may produce 
some factor essential for triggering of B  cells. 
The technical assistance of Mrs. Margery Little, Miss Ludmila Ptschelinzew, and Miss Jill 
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